Details of the Drug Combinations

General Information of This Drug (ID: DMLNFWU)

Drug Name
TEM   DMLNFWU
Synonyms Senrebotase
Indication
Disease Entry ICD 11 Status REF
Postherpetic neuralgia 1E91.5 Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

446 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
10-hydroxycamptothecin + TEM DC763Y7 10-hydroxycamptothecin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
ABIRATERONE + TEM DCG0EOS ABIRATERONE Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
ABIRATERONE + TEM DC8HROL ABIRATERONE Clear cell renal cell carcinoma (Cell Line: A498) [3]
ABIRATERONE + TEM DC7UZ0R ABIRATERONE Papillary renal cell carcinoma (Cell Line: ACHN) [3]
ABIRATERONE + TEM DC5GL54 ABIRATERONE Colon adenocarcinoma (Cell Line: COLO 205) [4]
ABIRATERONE + TEM DC7OVII ABIRATERONE Invasive ductal carcinoma (Cell Line: T-47D) [4]
ABIRATERONE + TEM DCFA13W ABIRATERONE Invasive ductal carcinoma (Cell Line: BT-549) [4]
ABIRATERONE + TEM DCDH8D0 ABIRATERONE Amelanotic melanoma (Cell Line: M14) [2]
ABIRATERONE + TEM DCYW02H ABIRATERONE Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
ABIRATERONE + TEM DCFC1A9 ABIRATERONE Melanoma (Cell Line: SK-MEL-2) [2]
ABIRATERONE + TEM DC8AUSH ABIRATERONE Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Amonafide + TEM DCV9D2B Amonafide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Arfolitixorin + TEM DCRJT9G Arfolitixorin Adenocarcinoma (Cell Line: HCT116) [2]
Arfolitixorin + TEM DC7FGX9 Arfolitixorin Adenocarcinoma (Cell Line: SW-620) [2]
Arfolitixorin + TEM DCS7SA7 Arfolitixorin Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Arfolitixorin + TEM DCLUYI5 Arfolitixorin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Arfolitixorin + TEM DCZSVYG Arfolitixorin Prostate carcinoma (Cell Line: PC-3) [2]
Azacitidine + TEM DCKJ61H Azacitidine Adenocarcinoma (Cell Line: NCIH23) [3]
Azacitidine + TEM DC4R34Z Azacitidine Malignant melanoma (Cell Line: UACC62) [3]
Bleomycin + TEM DC107QR Bleomycin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Cabazitaxel + TEM DCJTBVH Cabazitaxel Melanoma (Cell Line: MALME-3M) [3]
Cabazitaxel + TEM DC7V8Q1 Cabazitaxel Carcinoma (Cell Line: RXF 393) [4]
Cabazitaxel + TEM DC4F0UC Cabazitaxel Invasive ductal carcinoma (Cell Line: T-47D) [4]
Crizotinib + TEM DC1PA03 Crizotinib Amelanotic melanoma (Cell Line: M14) [3]
Crizotinib + TEM DCV9WVR Crizotinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Crizotinib + TEM DCJV3LJ Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Crizotinib + TEM DCICXS9 Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Crizotinib + TEM DCVH95L Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Crizotinib + TEM DC9HA8T Crizotinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Crizotinib + TEM DCOV9FQ Crizotinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Crizotinib + TEM DCXDRCC Crizotinib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Crizotinib + TEM DC5URN2 Crizotinib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Crizotinib + TEM DCNXLFV Crizotinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dacarbazine + TEM DCZKVSH Dacarbazine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + TEM DCDDMZD Dacarbazine Prostate carcinoma (Cell Line: PC-3) [3]
Dactinomycin + TEM DC7OISJ Dactinomycin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dasatinib + TEM DCR8B8J Dasatinib Astrocytoma (Cell Line: U251) [3]
Dasatinib + TEM DC9507V Dasatinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Dasatinib + TEM DCAANJX Dasatinib Melanoma (Cell Line: MALME-3M) [3]
Dasatinib + TEM DCZ42HM Dasatinib Colon carcinoma (Cell Line: KM12) [4]
Dasatinib + TEM DCC61KH Dasatinib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Dexrazoxane + TEM DCQZE67 Dexrazoxane Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
DFN-15 + TEM DCFDEJ7 DFN-15 Astrocytoma (Cell Line: SNB-19) [3]
Docetaxel + TEM DCVMKQR Docetaxel Adenocarcinoma (Cell Line: DU-145) [3]
Docetaxel + TEM DCAYZPH Docetaxel Adenocarcinoma (Cell Line: NCIH23) [3]
Docetaxel + TEM DCW6D3B Docetaxel Adenocarcinoma (Cell Line: A549) [3]
Docetaxel + TEM DCBZCY4 Docetaxel Adenocarcinoma (Cell Line: HT29) [3]
Docetaxel + TEM DCM63NK Docetaxel Adenocarcinoma (Cell Line: HCC-2998) [3]
Docetaxel + TEM DCTJQ77 Docetaxel Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Docetaxel + TEM DCQ1Z0F Docetaxel Anaplastic large cell lymphoma (Cell Line: SR) [3]
Docetaxel + TEM DC0EI81 Docetaxel Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Docetaxel + TEM DC2DWMP Docetaxel Glioblastoma (Cell Line: SNB-75) [3]
Docetaxel + TEM DCXI9AB Docetaxel Glioma (Cell Line: SF-268) [3]
Docetaxel + TEM DC1M1XR Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Docetaxel + TEM DCIDAJJ Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Docetaxel + TEM DCMXWFN Docetaxel Lung adenocarcinoma (Cell Line: HOP-62) [3]
Docetaxel + TEM DCFHE0D Docetaxel Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Docetaxel + TEM DCV9UZ2 Docetaxel Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Docetaxel + TEM DC4R28R Docetaxel Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Docetaxel + TEM DCUEMAW Docetaxel Prostate carcinoma (Cell Line: PC-3) [3]
Docetaxel + TEM DCPMIFU Docetaxel Colon adenocarcinoma (Cell Line: COLO 205) [4]
Docetaxel + TEM DCK0H2X Docetaxel Invasive ductal carcinoma (Cell Line: BT-549) [4]
Docetaxel + TEM DCRE9KD Docetaxel Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Epirubicin + TEM DCJ3N74 Epirubicin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Epirubicin + TEM DCNCA6D Epirubicin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Epirubicin + TEM DCEB43V Epirubicin Glioma (Cell Line: SF-268) [3]
Epirubicin + TEM DCWP62Q Epirubicin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Epirubicin + TEM DCIIE1W Epirubicin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Epirubicin + TEM DCYHAKF Epirubicin Adenocarcinoma (Cell Line: HT29) [2]
Epirubicin + TEM DCYB0Z8 Epirubicin Adenocarcinoma (Cell Line: HCT-15) [2]
Epirubicin + TEM DCBJNFO Epirubicin Amelanotic melanoma (Cell Line: M14) [2]
Epirubicin + TEM DC70QNA Epirubicin Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Epirubicin + TEM DCZO2JV Epirubicin Melanoma (Cell Line: SK-MEL-2) [2]
Epirubicin + TEM DCIYWUD Epirubicin Melanoma (Cell Line: UACC-257) [2]
Epirubicin + TEM DCULZI6 Epirubicin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Estramustine + TEM DCHPXZP Estramustine Adenocarcinoma (Cell Line: DU-145) [2]
Fulvestrant + TEM DC58OY1 Fulvestrant Renal cell carcinoma (Cell Line: UO-31) [3]
Fulvestrant + TEM DCM41XV Fulvestrant Renal cell carcinoma (Cell Line: SN12C) [3]
Fulvestrant + TEM DCI48WJ Fulvestrant Carcinoma (Cell Line: RXF 393) [4]
Gefitinib + TEM DCWJMKA Gefitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Gefitinib + TEM DCB9KXT Gefitinib Amelanotic melanoma (Cell Line: M14) [3]
Hepzato + TEM DCXTN17 Hepzato Astrocytoma (Cell Line: U251) [3]
Hepzato + TEM DC2TA3A Hepzato Astrocytoma (Cell Line: SNB-19) [3]
Hepzato + TEM DCN17TL Hepzato Glioma (Cell Line: SF-295) [3]
Hepzato + TEM DCZ1CSG Hepzato Invasive ductal carcinoma (Cell Line: T-47D) [4]
Hepzato + TEM DCCBBXH Hepzato Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Hepzato + TEM DCF77QR Hepzato Adenocarcinoma (Cell Line: SW-620) [2]
Hepzato + TEM DC3DB6L Hepzato Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Hepzato + TEM DCGVE6T Hepzato Amelanotic melanoma (Cell Line: M14) [2]
Idarubicin + TEM DCU3F4J Idarubicin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Idarubicin + TEM DC8OU7E Idarubicin Astrocytoma (Cell Line: SNB-19) [3]
Idarubicin + TEM DCCNJJX Idarubicin Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Idarubicin + TEM DCG6FPC Idarubicin Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Idarubicin + TEM DCKMWFC Idarubicin Malignant melanoma (Cell Line: LOX IMVI) [2]
Imatinib + TEM DCQ5ZKZ Imatinib Adenocarcinoma (Cell Line: NCIH23) [3]
Indazole derivative 5 + TEM DCVVLQT Indazole derivative 5 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Indazole derivative 5 + TEM DCJ9UAA Indazole derivative 5 Colon adenocarcinoma (Cell Line: COLO 205) [4]
Indazole derivative 5 + TEM DCXPTRU Indazole derivative 5 Invasive ductal carcinoma (Cell Line: T-47D) [4]
Indazole derivative 5 + TEM DCNQZ7E Indazole derivative 5 Invasive ductal carcinoma (Cell Line: BT-549) [4]
Indazole derivative 5 + TEM DCV19MO Indazole derivative 5 Adenocarcinoma (Cell Line: DU-145) [2]
Indazole derivative 5 + TEM DCCB258 Indazole derivative 5 Adenocarcinoma (Cell Line: HT29) [2]
Indazole derivative 5 + TEM DC7I5VT Indazole derivative 5 Amelanotic melanoma (Cell Line: M14) [2]
Indazole derivative 5 + TEM DCIJ9XK Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Indazole derivative 5 + TEM DC39CXQ Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Indazole derivative 5 + TEM DCLANZG Indazole derivative 5 Lung adenocarcinoma (Cell Line: HOP-62) [2]
Indazole derivative 5 + TEM DCRHE85 Indazole derivative 5 Melanoma (Cell Line: SK-MEL-2) [2]
Indazole derivative 5 + TEM DCE56V4 Indazole derivative 5 Melanoma (Cell Line: UACC-257) [2]
Indazole derivative 5 + TEM DCVFD3V Indazole derivative 5 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
JNK-IN-8 + TEM DCAK45W JNK-IN-8 Colon carcinoma (Cell Line: KM12) [4]
JNK-IN-8 + TEM DCF5G66 JNK-IN-8 Adenocarcinoma (Cell Line: SW-620) [2]
JNK-IN-8 + TEM DC4RIDX JNK-IN-8 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Lapatinib + TEM DC8MRNT Lapatinib Adenocarcinoma (Cell Line: HT29) [2]
Lapatinib + TEM DCQA4Z4 Lapatinib Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Lapatinib + TEM DC17218 Lapatinib Glioma (Cell Line: SF-295) [2]
Lapatinib + TEM DCMH100 Lapatinib Lung adenocarcinoma (Cell Line: HOP-62) [2]
Lapatinib + TEM DC9AGA4 Lapatinib Malignant melanoma (Cell Line: LOX IMVI) [2]
Letrozole + TEM DCZTV44 Letrozole Astrocytoma (Cell Line: U251) [3]
Letrozole + TEM DC08XET Letrozole Prostate carcinoma (Cell Line: PC-3) [3]
Letrozole + TEM DCHSA7A Letrozole Invasive ductal carcinoma (Cell Line: HS 578T) [4]
LIAROZOLE + TEM DCOU4E2 LIAROZOLE Adenocarcinoma (Cell Line: HT29) [2]
Mechlorethamine + TEM DCYPMT1 Mechlorethamine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Mechlorethamine + TEM DCQ86L3 Mechlorethamine Renal cell carcinoma (Cell Line: SN12C) [3]
Mechlorethamine + TEM DCRSEXV Mechlorethamine Colon carcinoma (Cell Line: KM12) [4]
Mechlorethamine + TEM DCRHOZH Mechlorethamine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Mechlorethamine + TEM DC9M383 Mechlorethamine Adenocarcinoma (Cell Line: NCIH23) [2]
Mechlorethamine + TEM DCU15WO Mechlorethamine Adenocarcinoma (Cell Line: A549) [2]
Mechlorethamine + TEM DC7YADA Mechlorethamine Adenocarcinoma (Cell Line: HCT116) [2]
Mechlorethamine + TEM DCWCAR0 Mechlorethamine Adenocarcinoma (Cell Line: SW-620) [2]
Mechlorethamine + TEM DCL34AP Mechlorethamine Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Mechlorethamine + TEM DCUURN3 Mechlorethamine Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Mechlorethamine + TEM DC5E0U8 Mechlorethamine Lung adenocarcinoma (Cell Line: HOP-62) [2]
Mechlorethamine + TEM DC553A3 Mechlorethamine Malignant melanoma (Cell Line: LOX IMVI) [2]
Mechlorethamine + TEM DC6IIXX Mechlorethamine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Mechlorethamine + TEM DCTAFW1 Mechlorethamine Prostate carcinoma (Cell Line: PC-3) [2]
Mepacrine + TEM DCUAMTD Mepacrine Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Mepacrine + TEM DCO0PR8 Mepacrine Glioma (Cell Line: SF-539) [3]
Mepacrine + TEM DCT5O0V Mepacrine Carcinoma (Cell Line: RXF 393) [4]
Mepacrine + TEM DCUTIEY Mepacrine Colon carcinoma (Cell Line: KM12) [4]
Mepacrine + TEM DCEIPFN Mepacrine Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Mepacrine + TEM DCK2COL Mepacrine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Nilotinib + TEM DCXYET5 Nilotinib Astrocytoma (Cell Line: SNB-19) [3]
Nilotinib + TEM DCK4VYI Nilotinib Melanoma (Cell Line: MALME-3M) [2]
Nilotinib + TEM DC0XY51 Nilotinib Melanoma (Cell Line: SK-MEL-2) [2]
Picoplatin + TEM DC0898C Picoplatin Adenocarcinoma (Cell Line: DU-145) [2]
Picoplatin + TEM DCVY6C4 Picoplatin Adenocarcinoma (Cell Line: HCT116) [2]
Picoplatin + TEM DCG8LNV Picoplatin Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Picoplatin + TEM DCTBUB2 Picoplatin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Picoplatin + TEM DCN37EB Picoplatin Prostate carcinoma (Cell Line: PC-3) [2]
PMID28460551-Compound-2 + TEM DC1UGM8 PMID28460551-Compound-2 Clear cell renal cell carcinoma (Cell Line: A498) [3]
PMID28460551-Compound-2 + TEM DCWS79G PMID28460551-Compound-2 Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Raloxifene + TEM DCG43CY Raloxifene Astrocytoma (Cell Line: U251) [3]
Raloxifene + TEM DC0KG0L Raloxifene Astrocytoma (Cell Line: SNB-19) [3]
Raloxifene + TEM DCWDEO8 Raloxifene Glioblastoma (Cell Line: SNB-75) [3]
Raloxifene + TEM DCED6J0 Raloxifene Glioma (Cell Line: SF-295) [3]
Raloxifene + TEM DCQUMVY Raloxifene Glioma (Cell Line: SF-268) [3]
Raloxifene + TEM DCF6RVK Raloxifene Carcinoma (Cell Line: MCF7) [4]
Raloxifene + TEM DC1VYFU Raloxifene Invasive ductal carcinoma (Cell Line: BT-549) [4]
Raloxifene + TEM DCX877Y Raloxifene Invasive ductal carcinoma (Cell Line: T-47D) [4]
Raloxifene + TEM DCYGTWQ Raloxifene Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Raloxifene + TEM DC4IYD7 Raloxifene Adenocarcinoma (Cell Line: DU-145) [2]
Raloxifene + TEM DCIZ8SE Raloxifene Adenocarcinoma (Cell Line: NCIH23) [2]
Raloxifene + TEM DC56MDP Raloxifene Adenocarcinoma (Cell Line: SW-620) [2]
Raloxifene + TEM DC7RDYV Raloxifene Adenocarcinoma (Cell Line: HT29) [2]
Raloxifene + TEM DCPUUVE Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Raloxifene + TEM DCLIT6X Raloxifene Lung adenocarcinoma (Cell Line: EKVX) [2]
Raloxifene + TEM DC40Y6C Raloxifene Lung adenocarcinoma (Cell Line: HOP-62) [2]
Raloxifene + TEM DCOV55H Raloxifene Malignant melanoma (Cell Line: UACC62) [2]
Raloxifene + TEM DC6KGS7 Raloxifene Melanoma (Cell Line: SK-MEL-2) [2]
Raloxifene + TEM DC5PAP6 Raloxifene Prostate carcinoma (Cell Line: PC-3) [2]
Ruxolitinib + TEM DC4M1QW Ruxolitinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Ruxolitinib + TEM DC75ILE Ruxolitinib Glioma (Cell Line: SF-268) [3]
Ruxolitinib + TEM DC7PIVX Ruxolitinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Ruxolitinib + TEM DCIIMHD Ruxolitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Ruxolitinib + TEM DC16QFY Ruxolitinib Carcinoma (Cell Line: RXF 393) [4]
Ruxolitinib + TEM DCJEM8R Ruxolitinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Ruxolitinib + TEM DCD2E8L Ruxolitinib Adenocarcinoma (Cell Line: NCIH23) [2]
Ruxolitinib + TEM DCTQU0V Ruxolitinib Adenocarcinoma (Cell Line: HCT-15) [2]
Ruxolitinib + TEM DCKS7CT Ruxolitinib Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Ruxolitinib + TEM DCSCDMH Ruxolitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Ruxolitinib + TEM DC79ZDF Ruxolitinib Lung adenocarcinoma (Cell Line: HOP-62) [2]
Ruxolitinib + TEM DCIVVC9 Ruxolitinib Melanoma (Cell Line: SK-MEL-2) [2]
Ruxolitinib + TEM DCU316K Ruxolitinib Melanoma (Cell Line: UACC-257) [2]
SCH 727965 + TEM DCEB8VI SCH 727965 Astrocytoma (Cell Line: U251) [3]
SCH 727965 + TEM DCN6ED9 SCH 727965 Colon adenocarcinoma (Cell Line: COLO 205) [4]
SCH 727965 + TEM DCVS7TD SCH 727965 Invasive ductal carcinoma (Cell Line: BT-549) [4]
SCH 727965 + TEM DCEYVAK SCH 727965 Adenocarcinoma (Cell Line: DU-145) [2]
SCH 727965 + TEM DCS8LO1 SCH 727965 Malignant melanoma (Cell Line: LOX IMVI) [2]
Sirolimus + TEM DCIBWUJ Sirolimus Astrocytoma (Cell Line: U251) [3]
Sirolimus + TEM DCTXNYM Sirolimus Astrocytoma (Cell Line: SNB-19) [3]
Sirolimus + TEM DC7DEDD Sirolimus Colon adenocarcinoma (Cell Line: COLO 205) [4]
Sirolimus + TEM DCHUZA7 Sirolimus Colon carcinoma (Cell Line: KM12) [4]
Sirolimus + TEM DC0FH7P Sirolimus Invasive ductal carcinoma (Cell Line: T-47D) [4]
Sirolimus + TEM DC7V6RP Sirolimus Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Sirolimus + TEM DCMI4P2 Sirolimus Adenocarcinoma (Cell Line: A549) [2]
Sirolimus + TEM DCWQUW4 Sirolimus Adenocarcinoma (Cell Line: HT29) [2]
Sirolimus + TEM DCEG8YH Sirolimus Melanoma (Cell Line: UACC-257) [2]
Sirolimus + TEM DCP7CLB Sirolimus Prostate carcinoma (Cell Line: PC-3) [2]
Sorafenib + TEM DC82QZF Sorafenib Adenocarcinoma (Cell Line: NCIH23) [3]
Sorafenib + TEM DCZ78P3 Sorafenib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Sorafenib + TEM DCSJ9RU Sorafenib Carcinoma (Cell Line: RXF 393) [4]
SY-1425 + TEM DCSSUD1 SY-1425 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
SY-1425 + TEM DC8FGGC SY-1425 Glioma (Cell Line: SF-268) [3]
SY-1425 + TEM DC2X2FE SY-1425 Colon adenocarcinoma (Cell Line: COLO 205) [4]
SY-1425 + TEM DCUPKHT SY-1425 Invasive ductal carcinoma (Cell Line: T-47D) [4]
SY-1425 + TEM DCR954W SY-1425 Adenocarcinoma (Cell Line: HCT116) [2]
SY-1425 + TEM DC80FIE SY-1425 Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
SY-1425 + TEM DCYFHO6 SY-1425 Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Taxol + TEM DCGEMV1 Taxol Adenocarcinoma (Cell Line: NCIH23) [2]
TEM + Pentostatin DCBR687 Pentostatin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
TEM + Pentostatin DCHZUNG Pentostatin Clear cell renal cell carcinoma (Cell Line: A498) [3]
TEM + Pentostatin DCW8RMC Pentostatin Glioma (Cell Line: SF-539) [3]
TEM + Dactinomycin DCCBGBJ Dactinomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
TEM + Methotrexate DC26Q2U Methotrexate Astrocytoma (Cell Line: SNB-19) [3]
TEM + Methotrexate DCE11Z3 Methotrexate Glioma (Cell Line: SF-295) [3]
TEM + Isoniazid DC1WBZP Isoniazid Glioblastoma (Cell Line: SNB-75) [3]
TEM + Plicamycin DCH5BPD Plicamycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
TEM + Plicamycin DCNMXK8 Plicamycin Astrocytoma (Cell Line: SNB-19) [3]
TEM + Plicamycin DCFRU0Y Plicamycin Glioblastoma (Cell Line: SNB-75) [3]
TEM + Plicamycin DCB6WIR Plicamycin Glioma (Cell Line: SF-539) [3]
TEM + Plicamycin DC11NMH Plicamycin Glioma (Cell Line: SF-295) [3]
TEM + Plicamycin DCCLU9M Plicamycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
TEM + Triapine DC66VY4 Triapine Astrocytoma (Cell Line: U251) [3]
TEM + Triapine DCCX209 Triapine Clear cell renal cell carcinoma (Cell Line: A498) [3]
TEM + Triapine DC36C95 Triapine Glioblastoma (Cell Line: SNB-75) [3]
TEM + Pralatrexate DCTRJZ2 Pralatrexate Clear cell renal cell carcinoma (Cell Line: A498) [3]
TEM + Pralatrexate DCFRD18 Pralatrexate Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
TEM + Pralatrexate DCSZL99 Pralatrexate Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
TEM + Pralatrexate DCMEHY4 Pralatrexate Papillary renal cell carcinoma (Cell Line: ACHN) [3]
TEM + Ifosfamide DC9GTJV Ifosfamide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
TEM + Ifosfamide DCFTB6I Ifosfamide Chronic myelogenous leukemia (Cell Line: K-562) [3]
TEM + Ifosfamide DC5CKJP Ifosfamide Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
TEM + Mitomycin DC7GF4E Mitomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
TEM + Mitomycin DCIUO88 Mitomycin Clear cell renal cell carcinoma (Cell Line: A498) [3]
TEM + Mitomycin DC30PFK Mitomycin Renal cell carcinoma (Cell Line: UO-31) [3]
TEM + Altretamine DCYE9HA Altretamine Astrocytoma (Cell Line: SNB-19) [3]
TEM + Altretamine DCD6FV5 Altretamine Clear cell renal cell carcinoma (Cell Line: A498) [3]
TEM + Altretamine DCN571O Altretamine Renal cell carcinoma (Cell Line: SN12C) [3]
TEM + Idarubicin DC268OV Idarubicin Glioblastoma? (Cell Line: T98G) [3]
TEM + Bleomycin DCNSHD7 Bleomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
TEM + Bortezomib DCOKGQH Bortezomib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
TEM + Cisplatin DC4N67B Cisplatin Glioma (Cell Line: SF-539) [3]
TEM + Chlorambucil DCUFPIS Chlorambucil Anaplastic large cell lymphoma (Cell Line: SR) [3]
TEM + Chlorambucil DCN6U6C Chlorambucil Clear cell renal cell carcinoma (Cell Line: A498) [3]
TEM + Chlorambucil DCEOJJ5 Chlorambucil Glioma (Cell Line: SF-295) [3]
TEM + ER819762 DCY88JM ER819762 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
TEM + ER819762 DC7WWH5 ER819762 Anaplastic large cell lymphoma (Cell Line: SR) [3]
TEM + ER819762 DCMCID3 ER819762 Glioma (Cell Line: SF-295) [3]
TEM + ER819762 DCO2IZ5 ER819762 Papillary renal cell carcinoma (Cell Line: ACHN) [3]
TEM + Pomalidomide DCOYA3Y Pomalidomide Chronic myelogenous leukemia (Cell Line: K-562) [3]
TEM + Mercaptopurine DCMR5OX Mercaptopurine Glioma (Cell Line: SF-268) [3]
TEM + PMID28870136-Compound-43 DCWU00A PMID28870136-Compound-43 Renal cell carcinoma (Cell Line: SN12C) [3]
TEM + FORMESTANE DCOL3RR FORMESTANE Renal cell carcinoma (Cell Line: SN12C) [3]
TEM + FORMESTANE DCLSU8Z FORMESTANE Renal cell carcinoma (Cell Line: UO-31) [3]
TEM + Aminolevulinic Acid Hydrochloride DCVQ1UG Aminolevulinic Acid Hydrochloride Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
TEM + Aminolevulinic Acid Hydrochloride DCUB7LJ Aminolevulinic Acid Hydrochloride Glioma (Cell Line: SF-268) [3]
TEM + Aminolevulinic Acid Hydrochloride DCSVA1P Aminolevulinic Acid Hydrochloride Papillary renal cell carcinoma (Cell Line: ACHN) [3]
TEM + Pentostatin DC142LO Pentostatin Carcinoma (Cell Line: RXF 393) [4]
TEM + Pentostatin DC3IXES Pentostatin Colon adenocarcinoma (Cell Line: COLO 205) [4]
TEM + Pentostatin DCDWS2U Pentostatin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
TEM + Plicamycin DCEL0MW Plicamycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
TEM + Plicamycin DC9SNV1 Plicamycin Carcinoma (Cell Line: RXF 393) [4]
TEM + Plicamycin DCOFKUM Plicamycin Invasive ductal carcinoma (Cell Line: BT-549) [4]
TEM + Triapine DCBRF1B Triapine Colon adenocarcinoma (Cell Line: COLO 205) [4]
TEM + Triapine DCWB9VU Triapine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
TEM + Triapine DCETXQ5 Triapine Invasive ductal carcinoma (Cell Line: T-47D) [4]
TEM + Pralatrexate DCGWX9B Pralatrexate Carcinoma (Cell Line: RXF 393) [4]
TEM + Pralatrexate DCZW6SD Pralatrexate Invasive ductal carcinoma (Cell Line: BT-549) [4]
TEM + Pralatrexate DCXQ07T Pralatrexate Invasive ductal carcinoma (Cell Line: T-47D) [4]
TEM + Mitomycin DC0551C Mitomycin Colon carcinoma (Cell Line: KM12) [4]
TEM + Mitomycin DCQXNK8 Mitomycin Invasive ductal carcinoma (Cell Line: T-47D) [4]
TEM + Altretamine DCQ9S40 Altretamine Colon adenocarcinoma (Cell Line: COLO 205) [4]
TEM + Altretamine DCYOYF6 Altretamine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
TEM + Chlorambucil DCY79E3 Chlorambucil Colon carcinoma (Cell Line: KM12) [4]
TEM + Chlorambucil DCBEJEF Chlorambucil Invasive ductal carcinoma (Cell Line: T-47D) [4]
TEM + Chlorambucil DCF4CMO Chlorambucil Invasive ductal carcinoma (Cell Line: BT-549) [4]
TEM + ER819762 DCZ695P ER819762 Carcinoma (Cell Line: RXF 393) [4]
TEM + Pomalidomide DCB8U5C Pomalidomide Colon adenocarcinoma (Cell Line: COLO 205) [4]
TEM + Mercaptopurine DCEBWX7 Mercaptopurine Carcinoma (Cell Line: RXF 393) [4]
TEM + FORMESTANE DCL9FZW FORMESTANE Invasive ductal carcinoma (Cell Line: T-47D) [4]
TEM + Aminolevulinic Acid Hydrochloride DCVI4ZS Aminolevulinic Acid Hydrochloride Invasive ductal carcinoma (Cell Line: T-47D) [4]
TEM + Aminolevulinic Acid Hydrochloride DCBV0GM Aminolevulinic Acid Hydrochloride Invasive ductal carcinoma (Cell Line: BT-549) [4]
TEM + Pentostatin DC7R8BR Pentostatin Adenocarcinoma (Cell Line: HCT-15) [2]
TEM + Pentostatin DCR6041 Pentostatin Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
TEM + Pentostatin DCLK6HM Pentostatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
TEM + Pentostatin DC25OME Pentostatin Lung adenocarcinoma (Cell Line: EKVX) [2]
TEM + Pentostatin DC16Z77 Pentostatin Melanoma (Cell Line: MALME-3M) [2]
TEM + Pentostatin DC02LMR Pentostatin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
TEM + Dactinomycin DCHHL4V Dactinomycin Adenocarcinoma (Cell Line: HCT-15) [2]
TEM + Dactinomycin DCQ3CM3 Dactinomycin Amelanotic melanoma (Cell Line: M14) [2]
TEM + Cyclophosphamide DCGGYXQ Cyclophosphamide Adenocarcinoma (Cell Line: OVCAR3) [2]
TEM + Cyclophosphamide DC9C321 Cyclophosphamide Adenocarcinoma (Cell Line: NCIH23) [2]
TEM + Cyclophosphamide DCVNZFG Cyclophosphamide Adenocarcinoma (Cell Line: HT29) [2]
TEM + Cyclophosphamide DCDM8N0 Cyclophosphamide Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
TEM + Cyclophosphamide DCLIQ4B Cyclophosphamide Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
TEM + Cyclophosphamide DCTLCFY Cyclophosphamide Malignant melanoma (Cell Line: UACC62) [2]
TEM + Methotrexate DC5E2JZ Methotrexate Adenocarcinoma (Cell Line: DU-145) [2]
TEM + Isoniazid DC2XMES Isoniazid Adenocarcinoma (Cell Line: A549) [2]
TEM + Isoniazid DCE2IVF Isoniazid Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
TEM + Isoniazid DCCOI2U Isoniazid Melanoma (Cell Line: MALME-3M) [2]
TEM + Plicamycin DCP4H8S Plicamycin Adenocarcinoma (Cell Line: OVCAR3) [2]
TEM + Plicamycin DC5YM0W Plicamycin Adenocarcinoma (Cell Line: A549) [2]
TEM + Plicamycin DC4XXKP Plicamycin Adenocarcinoma (Cell Line: HCT116) [2]
TEM + Plicamycin DCNLG8M Plicamycin Adenocarcinoma (Cell Line: HT29) [2]
TEM + Plicamycin DCUQ0MS Plicamycin Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
TEM + Plicamycin DC209IE Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
TEM + Plicamycin DCB90HT Plicamycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
TEM + Plicamycin DCNBSHT Plicamycin Melanoma (Cell Line: MALME-3M) [2]
TEM + Plicamycin DCP7XKZ Plicamycin Melanoma (Cell Line: UACC-257) [2]
TEM + Plicamycin DC8HEOG Plicamycin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
TEM + Plicamycin DC6JBOK Plicamycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
TEM + Triapine DCH5LY8 Triapine Adenocarcinoma (Cell Line: OVCAR3) [2]
TEM + Triapine DCTI9PD Triapine Adenocarcinoma (Cell Line: A549) [2]
TEM + Triapine DC3GGAO Triapine Adenocarcinoma (Cell Line: HCC-2998) [2]
TEM + Triapine DCH36GV Triapine Adenocarcinoma (Cell Line: HCT116) [2]
TEM + Triapine DCXH4UQ Triapine Adenocarcinoma (Cell Line: HCT-15) [2]
TEM + Triapine DCO7ICO Triapine Melanoma (Cell Line: MALME-3M) [2]
TEM + Triapine DCCNG2S Triapine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
TEM + Triapine DC9N4RH Triapine Prostate carcinoma (Cell Line: PC-3) [2]
TEM + Pralatrexate DCN7M1F Pralatrexate Adenocarcinoma (Cell Line: HT29) [2]
TEM + Pralatrexate DCWZKMY Pralatrexate Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
TEM + Pralatrexate DCKB49D Pralatrexate Prostate carcinoma (Cell Line: PC-3) [2]
TEM + Ifosfamide DCNN149 Ifosfamide Adenocarcinoma (Cell Line: DU-145) [2]
TEM + Ifosfamide DC6AX9H Ifosfamide Adenocarcinoma (Cell Line: HCT116) [2]
TEM + Ifosfamide DCK5VOV Ifosfamide Lung adenocarcinoma (Cell Line: HOP-62) [2]
TEM + Ifosfamide DC3RAQH Ifosfamide Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
TEM + Ifosfamide DC8HHYB Ifosfamide Melanoma (Cell Line: UACC-257) [2]
TEM + Ifosfamide DCLTF24 Ifosfamide Melanoma (Cell Line: SK-MEL-2) [2]
TEM + Ifosfamide DCGBAII Ifosfamide Prostate carcinoma (Cell Line: PC-3) [2]
TEM + Mitomycin DCM3PFL Mitomycin Adenocarcinoma (Cell Line: OVCAR3) [2]
TEM + Mitomycin DCXYE3Y Mitomycin Adenocarcinoma (Cell Line: A549) [2]
TEM + Mitomycin DCOZ6MQ Mitomycin Adenocarcinoma (Cell Line: HCC-2998) [2]
TEM + Altretamine DCTFH1A Altretamine Adenocarcinoma (Cell Line: HCT116) [2]
TEM + Altretamine DC2AWUL Altretamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [2]
TEM + Altretamine DC276NB Altretamine Malignant melanoma (Cell Line: LOX IMVI) [2]
TEM + Altretamine DC81Q8J Altretamine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
TEM + Altretamine DC5EWEH Altretamine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
TEM + Bleomycin DC7RYQN Bleomycin Lung adenocarcinoma (Cell Line: EKVX) [2]
TEM + Bleomycin DCH9OR1 Bleomycin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
TEM + Chlorambucil DCY2W90 Chlorambucil Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
TEM + Chlorambucil DCS0ZNS Chlorambucil High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
TEM + Chlorambucil DC67PDZ Chlorambucil High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
TEM + Chlorambucil DCC2IE2 Chlorambucil Lung adenocarcinoma (Cell Line: HOP-62) [2]
TEM + Chlorambucil DCJEQV9 Chlorambucil Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
TEM + ER819762 DC6QEMY ER819762 Adenocarcinoma (Cell Line: OVCAR3) [2]
TEM + ER819762 DCU0X00 ER819762 Adenocarcinoma (Cell Line: HCC-2998) [2]
TEM + ER819762 DCU9SGC ER819762 Lung adenocarcinoma (Cell Line: EKVX) [2]
TEM + Pomalidomide DC99ZQN Pomalidomide Adenocarcinoma (Cell Line: OVCAR3) [2]
TEM + Pomalidomide DCDBUBK Pomalidomide Adenocarcinoma (Cell Line: HCT116) [2]
TEM + Pomalidomide DCKYQFV Pomalidomide Melanoma (Cell Line: UACC-257) [2]
TEM + Pomalidomide DCSTNZZ Pomalidomide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
TEM + Mercaptopurine DCJ3DLT Mercaptopurine Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
TEM + Mercaptopurine DCT7BAC Mercaptopurine Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
TEM + PMID28870136-Compound-43 DCDR3LU PMID28870136-Compound-43 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [2]
TEM + FORMESTANE DCTBONO FORMESTANE Adenocarcinoma (Cell Line: HCT-15) [2]
TEM + FORMESTANE DC7XHSW FORMESTANE Malignant melanoma (Cell Line: LOX IMVI) [2]
TEM + FORMESTANE DCBE6I8 FORMESTANE Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
TEM + Aminolevulinic Acid Hydrochloride DCNZPHC Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: DU-145) [2]
TEM + Aminolevulinic Acid Hydrochloride DCQN8Y1 Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: A549) [2]
TEM + Aminolevulinic Acid Hydrochloride DC31L29 Aminolevulinic Acid Hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [2]
TEM + Aminolevulinic Acid Hydrochloride DC1CKPZ Aminolevulinic Acid Hydrochloride Lung adenocarcinoma (Cell Line: HOP-62) [2]
TEM + Aminolevulinic Acid Hydrochloride DCDGDPN Aminolevulinic Acid Hydrochloride Melanoma (Cell Line: MALME-3M) [2]
TEM + Busulfan DCMT7OV Busulfan Adenocarcinoma (Cell Line: OVCAR3) [2]
TEM + Busulfan DCDVIRC Busulfan Adenocarcinoma (Cell Line: HT29) [2]
TEM + Busulfan DCTWY31 Busulfan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [2]
Terameprocol + TEM DCQ9Q5Y Terameprocol Anaplastic large cell lymphoma (Cell Line: SR) [3]
Terameprocol + TEM DCZX1B5 Terameprocol Renal cell carcinoma (Cell Line: UO-31) [3]
Terameprocol + TEM DCTLQYJ Terameprocol Renal cell carcinoma (Cell Line: SN12C) [3]
Terameprocol + TEM DC3M1JX Terameprocol Melanoma (Cell Line: SK-MEL-2) [2]
Thioguanine + TEM DC6ZMJP Thioguanine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Thioguanine + TEM DCOTFBY Thioguanine Prostate carcinoma (Cell Line: PC-3) [2]
Topotecan + TEM DCF2LB2 Topotecan Carcinoma (Cell Line: MCF7) [4]
Topotecan + TEM DCEJYM4 Topotecan Adenocarcinoma (Cell Line: HCT116) [2]
Topotecan + TEM DCZ1FQP Topotecan Adenocarcinoma (Cell Line: SW-620) [2]
Topotecan + TEM DC271N6 Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Topotecan + TEM DCPCRJ2 Topotecan Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Topotecan + TEM DCM6HJV Topotecan Astrocytoma (Cell Line: SNB-19) [2]
Topotecan + TEM DCIX18S Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Topotecan + TEM DCYJOD3 Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Topotecan + TEM DC9ZREI Topotecan Lung adenocarcinoma (Cell Line: EKVX) [2]
Topotecan + TEM DCBO1EW Topotecan Melanoma (Cell Line: MALME-3M) [2]
Topotecan + TEM DCVPMNS Topotecan Melanoma (Cell Line: UACC-257) [2]
Topotecan + TEM DCOHWM3 Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Topotecan + TEM DCHRHF3 Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Topotecan + TEM DCL76XU Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Topotecan + TEM DC7HDPD Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Topotecan + TEM DCR0EXB Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Topotecan + TEM DCIWFSG Topotecan Prostate carcinoma (Cell Line: PC-3) [2]
Topotecan + TEM DCT0VAV Topotecan Renal cell carcinoma (Cell Line: SN12C) [2]
Trifluridine + TEM DCJZWC5 Trifluridine Adenocarcinoma (Cell Line: SW-620) [2]
Valrubicin + TEM DCXAYO8 Valrubicin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Valrubicin + TEM DCP3OS1 Valrubicin Amelanotic melanoma (Cell Line: M14) [2]
Valrubicin + TEM DC1M76E Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Valrubicin + TEM DCKC3O4 Valrubicin Lung adenocarcinoma (Cell Line: HOP-62) [2]
Valrubicin + TEM DC1H6AQ Valrubicin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Valrubicin + TEM DCPM4DH Valrubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Valrubicin + TEM DCK6V9D Valrubicin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Vandetanib + TEM DCI3H85 Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vandetanib + TEM DC2ZCZN Vandetanib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vandetanib + TEM DCN0F3L Vandetanib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vandetanib + TEM DC368YM Vandetanib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vandetanib + TEM DCGOC9X Vandetanib Amelanotic melanoma (Cell Line: M14) [2]
Vandetanib + TEM DC2KGMU Vandetanib Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Vandetanib + TEM DCQXQ1L Vandetanib Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Vandetanib + TEM DC8Q0LC Vandetanib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Vandetanib + TEM DCGF3KY Vandetanib Melanoma (Cell Line: SK-MEL-2) [2]
Vemurafenib + TEM DCMU2P2 Vemurafenib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vemurafenib + TEM DCA74QS Vemurafenib Carcinoma (Cell Line: RXF 393) [4]
Vemurafenib + TEM DCF32SD Vemurafenib Adenocarcinoma (Cell Line: DU-145) [2]
Vemurafenib + TEM DC3QTEN Vemurafenib Adenocarcinoma (Cell Line: NCIH23) [2]
Vemurafenib + TEM DCYWUVZ Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Vemurafenib + TEM DCN4LMR Vemurafenib Glioma (Cell Line: SF-295) [2]
Vemurafenib + TEM DCEHE2P Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [2]
Vemurafenib + TEM DCE0D6V Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Vemurafenib + TEM DC1N1R7 Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Vemurafenib + TEM DCUKLVP Vemurafenib Lung adenocarcinoma (Cell Line: EKVX) [2]
Vemurafenib + TEM DC3T3G5 Vemurafenib Lung adenocarcinoma (Cell Line: HOP-62) [2]
Vemurafenib + TEM DCN2CQC Vemurafenib Melanoma (Cell Line: SK-MEL-2) [2]
Vemurafenib + TEM DCPE7K0 Vemurafenib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Vemurafenib + TEM DCJL033 Vemurafenib Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Vemurafenib + TEM DCO5CVJ Vemurafenib Renal cell carcinoma (Cell Line: SN12C) [2]
Vincristine + TEM DCJO0F3 Vincristine Adenocarcinoma (Cell Line: DU-145) [3]
Vincristine + TEM DCFZMBV Vincristine Astrocytoma (Cell Line: SNB-19) [3]
Vincristine + TEM DCA5AHJ Vincristine Prostate carcinoma (Cell Line: PC-3) [3]
Vincristine + TEM DCR1861 Vincristine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vinflunine + TEM DCL4VPS Vinflunine Adenocarcinoma (Cell Line: A549) [2]
Vismodegib + TEM DC9FO58 Vismodegib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vismodegib + TEM DCSP5KR Vismodegib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vismodegib + TEM DCLIBKC Vismodegib Adenocarcinoma (Cell Line: HT29) [2]
Vismodegib + TEM DCZXHUL Vismodegib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Vismodegib + TEM DCU3ORN Vismodegib Amelanotic melanoma (Cell Line: M14) [2]
Vismodegib + TEM DC8MFP0 Vismodegib Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Vismodegib + TEM DCRYLTX Vismodegib Anaplastic large cell lymphoma (Cell Line: SR) [2]
Vismodegib + TEM DC5G399 Vismodegib Astrocytoma (Cell Line: SNB-19) [2]
Vismodegib + TEM DCP4JCI Vismodegib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Vismodegib + TEM DCY13ST Vismodegib Chronic myelogenous leukemia (Cell Line: K-562) [2]
Vismodegib + TEM DCFHMZB Vismodegib Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Vismodegib + TEM DC56XXU Vismodegib Glioma (Cell Line: SF-268) [2]
Vismodegib + TEM DCDHEJZ Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Vismodegib + TEM DCH1L8R Vismodegib Lung adenocarcinoma (Cell Line: HOP-62) [2]
Vismodegib + TEM DCTSSHO Vismodegib Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
Vismodegib + TEM DCR1CDH Vismodegib Malignant melanoma (Cell Line: LOX IMVI) [2]
Vismodegib + TEM DC4398N Vismodegib Malignant melanoma (Cell Line: UACC62) [2]
Vismodegib + TEM DC8OCUF Vismodegib Melanoma (Cell Line: UACC-257) [2]
Vismodegib + TEM DC012X8 Vismodegib Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Vismodegib + TEM DC8IQ00 Vismodegib Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Vismodegib + TEM DCAIRNR Vismodegib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 446 DrugCom(s)

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030055)
2 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.